Trials / Unknown
UnknownNCT00563927
Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)
Prospective Randomized Study on Therapeutic Gain Achieved By Addition of Chemotherapy for T1-4N2-3M0 Nasopharyngeal Carcinoma
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 340 (estimated)
- Sponsor
- Hospital Authority, Hong Kong · Other Government
- Sex
- All
- Age
- 70 Years
- Healthy volunteers
- —
Summary
To test the therapeutic ratio of additional chemotheray on advanced nasopharyngeal carcinoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Conventional RT | |
| DRUG | Cisplatin | |
| DRUG | 5-fluorouracil |
Timeline
- Start date
- 1999-03-01
- Completion
- 2009-10-01
- First posted
- 2007-11-26
- Last updated
- 2010-07-07
Locations
4 sites across 1 country: China
Source: ClinicalTrials.gov record NCT00563927. Inclusion in this directory is not an endorsement.